scholarly journals Mammary tumors and mammary tumor virus expression in hybrid mice of strains C57BL and GR.

1977 ◽  
Vol 146 (5) ◽  
pp. 1206-1220 ◽  
Author(s):  
W E Heston ◽  
W P Parks

Mammary tumorigenesis in genetic crosses between the high mammary tumor incidence GR and the low incidence C57BL mouse strains is highly correlated with murine mammary tumor virus expression in milk. Although the F1 and first backcross females had a mammary tumor incidence which was consistent with a single dominant gene segregation, the tumor incidence in the critical second backcross segregants disproved the single gene hypothesis. Genetic factors were clearly involved in regulation of virus expression which in turn correlated with both tumor incidence and tumor latency; these complex phenotypes are however best explained as threshold or quasicontinuous characters. As predicted from this model, the age specific incidence of mammary tumors showed a broad peak at 14-19 mo of age with no evidence of an early or late phase. Hematopoietic tumors showed no correlation with virus expression or mammary tumorigenesis suggesting different etiologies for these tumors.

Virology ◽  
1980 ◽  
Vol 100 (1) ◽  
pp. 101-109 ◽  
Author(s):  
Vincent L. Morris ◽  
Janet E. Vlasschaert ◽  
Cynthia L. Beard ◽  
Mark F. Milazzo ◽  
Wayne C. Bradbury

1987 ◽  
Vol 36 (2) ◽  
pp. 119-123 ◽  
Author(s):  
Atsuko Aoyama ◽  
Shoichi Nagayoshi ◽  
Shinsuke Saga ◽  
Jollyanna Malavasi-Yamashiro ◽  
Toyoharu Yokoi ◽  
...  

1978 ◽  
Vol 64 (2) ◽  
pp. 103-114
Author(s):  
Francesco Squartini ◽  
Giancarlo Di Coscio

The sperm collected from mammary tumor virus (MTV)-carrying mice (C3H, BALB/cfC3H, BALB/cfRIII and RIII) was separately tested for mammary tumor-inducing activity in (BALB/c × C3Hf)F1, (BALB/c × RIIIf)F1, and BALB/c female recipients by i.p. injection of 0.1 ml of the sperm at 1–2 weeks or at 3 months of age. A total of 551 recipients was observed, including control mice. The results may be summarized as follows: 1) mammary tumor incidence in experiments with or without histocompatibility between sperm donor and recipient is the same; 2) bioactivity is related to the type of MTV (C3H, RIII) and to the type of recipient, not to the sperm donor; 3) the activity of RIII MTV released in the sperm appears to be less influenced by the age of recipients than is that of C3H MTV; 4) BALB/c recipients are more susceptible to C3H than to RIII sperm-released MTV; 5) (BALB/c × RIIIf)F1 hybrids are resistant to sperm-released MTV, especially to C3H MTV infection, and show a 34% incidence of late spontaneous lymphomas inherited by the RIIIf male parent; 6) (BALB/c × C3Hf)F1 hybrids are susceptible to both C3H and RIII sperm-released MTV and show a 30% incidence of late spontaneous mammary tumors due to genetic transmission of MTV by the C3Hf male parent.


Sign in / Sign up

Export Citation Format

Share Document